Voronoi Future Growth
Future criteria checks 2/6
Voronoi is forecast to grow earnings and revenue by 4.6% and 40.7% per annum respectively while EPS is expected to grow by 6.8% per annum.
Key information
4.6%
Earnings growth rate
6.8%
EPS growth rate
Biotechs earnings growth | 65.5% |
Revenue growth rate | 40.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 May 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -34,000 | -31,000 | -31,000 | 1 |
12/31/2025 | 12,000 | -31,000 | -27,000 | -27,000 | 1 |
12/31/2024 | N/A | -38,000 | -34,000 | -34,000 | 1 |
6/30/2024 | N/A | -36,066 | -28,095 | -27,210 | N/A |
3/31/2024 | N/A | -35,040 | -27,951 | -27,098 | N/A |
12/31/2023 | N/A | -36,848 | -29,931 | -28,849 | N/A |
9/30/2023 | 589 | -30,991 | -27,157 | -26,022 | N/A |
6/30/2023 | 7,943 | -22,876 | -19,738 | -18,876 | N/A |
3/31/2023 | 8,630 | -22,143 | -17,500 | -16,744 | N/A |
12/31/2022 | 9,768 | -19,900 | -16,887 | -16,335 | N/A |
9/30/2022 | 13,845 | -14,095 | -12,843 | -12,558 | N/A |
6/30/2022 | 12,167 | -18,108 | -19,806 | -19,568 | N/A |
3/31/2022 | 14,419 | -18,833 | -17,044 | -16,740 | N/A |
12/31/2021 | 14,784 | -15,096 | -18,223 | -17,640 | N/A |
9/30/2021 | 16,095 | -12,472 | -15,420 | -14,940 | N/A |
12/31/2020 | 6,180 | -23,187 | -16,272 | -15,895 | N/A |
12/31/2019 | 301 | -50,003 | -39,323 | -33,634 | N/A |
12/31/2018 | 174 | -9,218 | -15,601 | -9,371 | N/A |
12/31/2017 | 34 | -1,882 | N/A | -2,280 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A310210 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: A310210 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: A310210 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: A310210's revenue (40.7% per year) is forecast to grow faster than the KR market (9.5% per year).
High Growth Revenue: A310210's revenue (40.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A310210's Return on Equity is forecast to be high in 3 years time